MY115155A
(en)
*
|
1993-09-09 |
2003-04-30 |
Upjohn Co |
Substituted oxazine and thiazine oxazolidinone antimicrobials.
|
US5688792A
(en)
*
|
1994-08-16 |
1997-11-18 |
Pharmacia & Upjohn Company |
Substituted oxazine and thiazine oxazolidinone antimicrobials
|
CA2174107C
(en)
*
|
1993-11-22 |
2005-04-12 |
Steven J. Brickner |
Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
|
JPH0873455A
(ja)
*
|
1994-03-15 |
1996-03-19 |
Upjohn Co:The |
オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
|
US5668286A
(en)
*
|
1994-03-15 |
1997-09-16 |
Pharmacia & Upjohn Company |
Oxazolidinone derivatives and pharmaceutical compositions containing them
|
DE4425612A1
(de)
*
|
1994-07-20 |
1996-04-04 |
Bayer Ag |
6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
|
MX9703543A
(es)
*
|
1994-11-15 |
1997-08-30 |
Upjohn Co |
Antibacterianos de oxazina biciclica y oxazolidinona tiazina.
|
DE69615002T2
(de)
*
|
1995-02-03 |
2002-06-13 |
Pharmacia & Upjohn Co., Kalamazoo |
Durch hetero-aromatische ring substituierte phenyloxazolidinone als antimikrobielles mittel
|
MX9708627A
(es)
*
|
1995-05-11 |
1998-02-28 |
Upjohn Co |
Oxazolidinonas de diazinilo y carbazinilo espirociclicas y biciclicas.
|
SK283487B6
(sk)
*
|
1995-09-01 |
2003-08-05 |
Pharmacia And Upjohn Company |
Fenyloxazolidinóny majúce C-C väzbu v 4 až 8 členných heterocyklických kruhoch
|
US5883093A
(en)
*
|
1995-09-12 |
1999-03-16 |
Pharmacia & Upjohn Company |
Phenyloxazolidinone antimicrobials
|
DE69631347T2
(de)
*
|
1995-09-15 |
2004-10-07 |
Upjohn Co |
Aminoaryl oxazolidinone n-oxide
|
ZA968661B
(en)
*
|
1995-11-17 |
1998-04-14 |
Upjohn Co |
Oxazolidinone antibacterial agent with tricyclic substituents.
|
ZA969622B
(en)
*
|
1995-12-13 |
1998-05-15 |
Upjohn Co |
Oxazolidinone antibacterial agents having a six-membered heteroaromatic ring.
|
GB9601666D0
(en)
*
|
1996-01-27 |
1996-03-27 |
Zeneca Ltd |
Chemical compounds
|
GB9702213D0
(en)
|
1996-02-24 |
1997-03-26 |
Zeneca Ltd |
Chemical compounds
|
MY116093A
(en)
*
|
1996-02-26 |
2003-11-28 |
Upjohn Co |
Azolyl piperazinyl phenyl oxazolidinone antimicrobials
|
SK284703B6
(sk)
*
|
1996-04-11 |
2005-09-08 |
Pharmacia & Upjohn Company |
Spôsob prípravy substituovaných oxazolidinón alkoholov
|
AT403803B
(de)
|
1996-04-19 |
1998-05-25 |
Sanochemia Ltd |
Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
|
GB9609919D0
(en)
|
1996-05-11 |
1996-07-17 |
Zeneca Ltd |
Chemical compounds
|
GB9614236D0
(en)
*
|
1996-07-06 |
1996-09-04 |
Zeneca Ltd |
Chemical compounds
|
GB9614238D0
(en)
*
|
1996-07-06 |
1996-09-04 |
Zeneca Ltd |
Chemical compounds
|
KR100307211B1
(ko)
*
|
1997-05-24 |
2001-11-30 |
손 경 식 |
옥사졸리디논유도체,이의제조방법및그를함유한항균제조성물
|
US6037354A
(en)
*
|
1997-06-18 |
2000-03-14 |
Merck & Co., Inc. |
Alpha 1a adrenergic receptor antagonists
|
KR20010021645A
(ko)
*
|
1997-07-11 |
2001-03-15 |
로렌스 티. 마이젠헬더 |
티아디아졸릴 및 옥사디아졸릴 페닐 옥사졸리디논 항균제
|
GB9717807D0
(en)
*
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
KR100467309B1
(ko)
*
|
1997-09-04 |
2005-07-18 |
씨제이 주식회사 |
옥사졸리디논유도체및그의제조방법및항균제조성물
|
KR100463111B1
(ko)
*
|
1997-10-30 |
2005-06-13 |
씨제이 주식회사 |
신규한옥사졸리디논유도체및제조방법및그를함유하는항균제조성물
|
KR100580408B1
(ko)
|
1997-11-07 |
2006-05-16 |
파마시아 앤드 업존 캄파니 엘엘씨 |
옥사졸리디논의 제조 방법
|
DK1030852T3
(da)
*
|
1997-11-12 |
2003-12-22 |
Upjohn Co |
Oxazolidinonderivater og farmaceutiske præparater
|
WO1999025344A1
(en)
*
|
1997-11-18 |
1999-05-27 |
Pharmacia & Upjohn Company |
Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
|
US6040306A
(en)
*
|
1997-11-18 |
2000-03-21 |
Pharmacia & Upjohn Company |
Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
|
DK1304107T3
(da)
*
|
1997-11-18 |
2005-08-22 |
Pharmacia & Upjohn Co Llc |
Anvendelse af oxozolidinonderivater til behandling af psoriasis
|
AU780197B2
(en)
*
|
1997-11-18 |
2005-03-10 |
Pharmacia & Upjohn Company |
Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
|
GB9725244D0
(en)
|
1997-11-29 |
1998-01-28 |
Zeneca Ltd |
Chemical compounds
|
US7002020B1
(en)
|
1998-01-23 |
2006-02-21 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
US6562844B2
(en)
|
1998-01-23 |
2003-05-13 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
BR9907183A
(pt)
|
1998-01-23 |
2003-06-10 |
Versicor Inc |
Colet neas combinatórias de oxazolidinona, composições e processos de preparação
|
JP2002503655A
(ja)
*
|
1998-02-13 |
2002-02-05 |
ファルマシア・アンド・アップジョン・カンパニー |
抗菌剤として有用な置換アミノフェニルイソオキサゾリン誘導体
|
AU753988B2
(en)
|
1998-06-05 |
2002-10-31 |
Astrazeneca Ab |
Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
|
GB9812019D0
(en)
*
|
1998-06-05 |
1998-07-29 |
Zeneca Ltd |
Chemical compounds
|
US6673799B1
(en)
*
|
1998-09-22 |
2004-01-06 |
Yamanouchi Pharmaceutical Co. Ltd. |
Cyanophenyl derivative
|
CA2351062A1
(en)
*
|
1998-11-27 |
2000-06-08 |
Pharmacia & Upjohn Company |
Oxazolidinone antibacterial agents having a thiocarbonyl functionality
|
JP2002535680A
(ja)
|
1999-01-27 |
2002-10-22 |
ファルマシア・アンド・アップジョン・カンパニー |
延長因子p活性モジュレーターのアッセイ方法
|
KR100333492B1
(ko)
*
|
1999-05-27 |
2002-04-25 |
박호군 |
이소옥사졸릴 메틸렌 옥사졸리디논 유도체 및 이의 제조방법
|
KR100333493B1
(ko)
*
|
1999-05-27 |
2002-04-25 |
박호군 |
이소옥사졸릴 카르보닐 옥사졸리디논 유도체 및 이의 제조방법
|
NZ516853A
(en)
*
|
1999-07-28 |
2003-11-28 |
Upjohn Co |
Oxazolidinones and their use as anti-infectives
|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
AR027261A1
(es)
*
|
2000-02-02 |
2003-03-19 |
Upjohn Co |
Linezolid forma cristalina ii
|
US6642238B2
(en)
|
2000-02-10 |
2003-11-04 |
Pharmacia And Upjohn Company |
Oxazolidinone thioamides with piperazine amide substituents
|
MY127336A
(en)
|
2000-03-22 |
2006-11-30 |
Upjohn Co |
Container for linezolid iv solution
|
US6514529B2
(en)
*
|
2000-03-22 |
2003-02-04 |
Pharmacia & Upjohn Company |
Oxazolidinone tablet formulation
|
GB0009803D0
(en)
|
2000-04-25 |
2000-06-07 |
Astrazeneca Ab |
Chemical compounds
|
HUP0301562A2
(hu)
|
2000-06-05 |
2003-12-29 |
Dong A Pharm. Co., Ltd. |
Új oxazolidinonszármazékok és eljárás ezek előállítására, ezeket tartalmazó gyógyszerkészítmények
|
DK1301207T3
(da)
|
2000-06-30 |
2005-10-10 |
Pharmacia & Upjohn Co Llc |
Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin
|
US6734307B2
(en)
*
|
2000-07-17 |
2004-05-11 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
ES2256318T3
(es)
|
2000-10-17 |
2006-07-16 |
PHARMACIA & UPJOHN COMPANY LLC |
Metodos de produccion de compuestos de oxazolidinona.
|
DE10129725A1
(de)
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Kombinationstherapie substituierter Oxazolidinone
|
ES2186550B2
(es)
*
|
2001-06-27 |
2003-11-16 |
Vita Lab |
Nuevos derivados de oxazolidinonas como antibacterianos.
|
US6956040B2
(en)
|
2001-07-16 |
2005-10-18 |
Ranbaxy Laboratories Limited |
Oxazolidinone piperazinyl derivatives as potential antimicrobials
|
EP1409464A4
(en)
*
|
2001-07-16 |
2005-11-02 |
Ranbaxy Lab Ltd |
OXAZOLIDINONE DERIVATIVES AS POTENTIAL ANTIMICROBIALS
|
US7125568B2
(en)
*
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
DE60205030T2
(de)
*
|
2001-09-11 |
2006-04-20 |
Astrazeneca Ab |
Oxazolidinon- und/oder isoxazolinderivate als antibakterielle mittel
|
WO2003035073A1
(en)
|
2001-10-25 |
2003-05-01 |
Astrazeneca Ab |
Isoxazoline derivatives useful as antimicrobials
|
JP2005519870A
(ja)
*
|
2001-10-25 |
2005-07-07 |
アストラゼネカ アクチボラグ |
抗菌活性をもつアリール置換オキサゾリジノン類
|
TW200302095A
(en)
*
|
2002-01-25 |
2003-08-01 |
Upjohn Co |
Oxazolidinone cotherapy
|
CA2475036A1
(en)
|
2002-02-05 |
2003-08-14 |
Gary W. Luehr |
Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections
|
AR038536A1
(es)
*
|
2002-02-25 |
2005-01-19 |
Upjohn Co |
N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
|
US7141588B2
(en)
*
|
2002-02-25 |
2006-11-28 |
Pfizer, Inc. |
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
|
JP2005527575A
(ja)
*
|
2002-03-29 |
2005-09-15 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
糖尿病性足病変感染を治療するためのオキサゾリジノンの非経口、静脈内および経口投与
|
WO2003082864A2
(en)
*
|
2002-04-01 |
2003-10-09 |
Cadila Healthcare Limited |
Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
|
JP2005529924A
(ja)
*
|
2002-05-15 |
2005-10-06 |
ランバクシー ラボラトリーズ リミテッド |
フェニルオキサゾリジノン誘導体
|
CN1668308A
(zh)
*
|
2002-07-29 |
2005-09-14 |
兰贝克赛实验室有限公司 |
作为抗菌剂的噁唑烷酮衍生物
|
WO2004014897A1
(en)
*
|
2002-08-12 |
2004-02-19 |
Pharmacia & Upjohn Company Llc |
N-aryl-2-oxazolidinones and their derivatives
|
AU2003253141A1
(en)
*
|
2002-08-22 |
2004-03-11 |
Orchid Chemicals And Pharmaceuticals Ltd |
Novel antibacterial agents
|
US20070167414A1
(en)
*
|
2002-08-22 |
2007-07-19 |
Orchid Chemicals & Pharmaceuticals Limited |
Novel antibacterial agents
|
WO2004026848A1
(en)
|
2002-09-20 |
2004-04-01 |
Lupin Limited |
Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
|
US6875784B2
(en)
*
|
2002-10-09 |
2005-04-05 |
Pharmacia & Upjohn Company |
Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
|
US7105547B2
(en)
|
2002-10-10 |
2006-09-12 |
Pharmacia And Upjohn Company |
Antimicrobial 1-aryl dihydropyridone compounds
|
AR042086A1
(es)
*
|
2002-11-21 |
2005-06-08 |
Upjohn Co |
N-aril-2- oxazolidinon -5- carboxamidas y sus derivados, usados como agentes antibacterianos
|
AU2002357561A1
(en)
*
|
2002-12-30 |
2004-07-22 |
Nanjing Chang'ao Pharmaceutical Science And Technology Limited Company |
Oxazolidine derivative, methods of preparation and uses
|
DE10300111A1
(de)
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
EP1594494A1
(en)
*
|
2003-02-07 |
2005-11-16 |
Warner-Lambert Company LLC |
Oxazolidinone derivatives n-substituted by a bicyclic ring, for use as antibacterial agents
|
JP2006516991A
(ja)
*
|
2003-02-07 |
2006-07-13 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
抗菌剤
|
US20040204463A1
(en)
*
|
2003-04-01 |
2004-10-14 |
Harris Christina Renee |
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
|
US20080214565A1
(en)
*
|
2003-04-07 |
2008-09-04 |
Anita Mehta |
Oxazolidinone Derivatives as Antimicrobials
|
WO2004113329A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Orchid Chemicals And Pharmaceuticals Ltd. |
Oxazole derivatives as antibacterial agents
|
EP1660488A1
(en)
*
|
2003-08-25 |
2006-05-31 |
Warner-Lambert Company LLC |
Novel antimicrobial aryloxazolidinone compounds
|
US7687627B2
(en)
*
|
2003-09-08 |
2010-03-30 |
Wockhardt Limited |
Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
|
US7304050B2
(en)
*
|
2003-09-16 |
2007-12-04 |
Pfizer Inc. |
Antibacterial agents
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
WO2005051933A1
(en)
*
|
2003-11-28 |
2005-06-09 |
Ranbaxy Laboratories Limited |
An improved process for the synthesis of 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylic acid tert-butyl ester, a key intermediate for oxazolidinone antimicrobials and compounds prepared thereby
|
KR100854211B1
(ko)
|
2003-12-18 |
2008-08-26 |
동아제약주식회사 |
신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
|
WO2005113520A1
(en)
*
|
2004-05-20 |
2005-12-01 |
Pharmacia & Upjohn Company Llc |
Substituted 2,3,5-trifluorphenyl oxazolidinones for use as antibacterial agents
|
US20060142283A1
(en)
*
|
2004-06-29 |
2006-06-29 |
Judith Aronhime |
Crystalline form IV of linezolid
|
WO2006040614A1
(en)
*
|
2004-10-11 |
2006-04-20 |
Ranbaxy Laboratories Limited |
Substituted oxazolidinone derivatives
|
EP1685841A1
(en)
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prevention and treatment of thromboembolic disorders
|
WO2006091731A2
(en)
*
|
2005-02-24 |
2006-08-31 |
Teva Pharmaceutical Industries Ltd. |
Processes for the preparation of linezolid intermediate
|
WO2006109156A1
(en)
|
2005-04-15 |
2006-10-19 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
EP1899331B1
(en)
|
2005-06-29 |
2009-11-25 |
Pharmacia & Upjohn Company LLC |
Homomorpholine oxazolidinones as antibacterial agents
|
DE102005045518A1
(de)
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
|
RU2578602C2
(ru)
|
2005-10-04 |
2016-03-27 |
Байер Интеллектуэль Проперти Гмбх |
Способ получения 5-хлор-n-(5s)-2-оксо-3-[4-(3-оксо-морфолинил)-фенил]-1,3-оксазолидин-5-ил}-метил)-2-тиофенкарбоксамида в модификации ii (варианты)
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
WO2008010070A2
(en)
*
|
2006-07-19 |
2008-01-24 |
Orchid Research Laboratories Limited |
Novel oxazolidinone derivatives
|
US7593630B2
(en)
|
2006-07-24 |
2009-09-22 |
Foxconn Technology Co., Ltd. |
Built-in multidriver device for a camera zoom lens
|
US20100298384A1
(en)
*
|
2006-12-04 |
2010-11-25 |
Mohamed Takhi |
Novel oxazolidinone compounds as antiinfective agents
|
DE102007018662A1
(de)
|
2007-04-20 |
2008-10-23 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von pulmonaler Hypertonie
|
DE102007028318A1
(de)
|
2007-06-20 |
2008-12-24 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von Sepsis
|
US20090093631A1
(en)
*
|
2007-09-06 |
2009-04-09 |
Ben-Zion Dolitzky |
Processes for the preparation of a linezolid intermediate, linezolid hydroxide
|
CN101965353B
(zh)
*
|
2008-03-26 |
2014-12-17 |
丹诺医药(苏州)有限公司 |
共价连接到取代苯基噁唑烷酮的双环硝基咪唑类
|
EP2138178A1
(en)
|
2008-06-28 |
2009-12-30 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidninones for the treatment fo chronic obstructive pulmonary disease (COPD) and/or asthma
|
EP2140866A1
(en)
|
2008-07-04 |
2010-01-06 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract
|
KR101674146B1
(ko)
|
2008-10-10 |
2016-11-08 |
머크 샤프 앤드 돔 코포레이션 |
옥사졸리디논 및 이를 포함하는 조성물을 제조하는 방법
|
JP5478499B2
(ja)
*
|
2008-10-27 |
2014-04-23 |
田辺三菱製薬株式会社 |
新規アミド誘導体およびその医薬としての用途
|
CA2743971A1
(en)
|
2008-11-20 |
2010-05-27 |
Panacea Biotec Ltd. |
Novel antimicrobials
|
CA2751392C
(en)
|
2009-02-03 |
2017-03-28 |
Trius Therapeutics, Inc. |
Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
|
US8580767B2
(en)
|
2009-05-28 |
2013-11-12 |
Trius Therapeutics, Inc. |
Oxazolidinone containing dimer compounds, compositions and methods to make and use
|
CN103360379B
(zh)
*
|
2012-03-31 |
2017-05-24 |
南京圣和药业股份有限公司 |
噁唑烷酮化合物
|
US10995097B2
(en)
*
|
2016-03-11 |
2021-05-04 |
The Board Of Trustees Of The University Of Illinois |
Small molecules active against gram-negative bacteria
|
WO2018237140A1
(en)
|
2017-06-23 |
2018-12-27 |
The Board Of Trustees Of The University Of Illinois |
TOPOISOMERASE INHIBITORS HAVING ANTIBACTERIAL ACTIVITY AND ANTI-CANCER ACTIVITY
|
US20210267953A1
(en)
|
2018-07-25 |
2021-09-02 |
Cadila Healthcare Limited |
Substituted oxazolidinones for the treatment of mammalian infections
|
CN110372624A
(zh)
*
|
2019-08-13 |
2019-10-25 |
北京海美桐医药科技有限公司 |
一种噁唑烷酮类化合物、其制备方法及应用
|
WO2021184339A1
(en)
*
|
2020-03-20 |
2021-09-23 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compound and methods of use thereof as an antibacterial agent
|
WO2024069378A1
(en)
*
|
2022-09-26 |
2024-04-04 |
Zydus Lifesciences Limited |
Novel compounds for the treatment of mammalian infections
|